Original Research Online Publishing Date: | ||||||||||||||||||||||||||||||
Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus? Nalini Vivek Mallya, Sreedhar Palakal, Dayananda G.
|
How to Cite this Article |
Pubmed Style Mallya NV, Palakal S, G D. Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?. Natl J Physiol Pharm Pharmacol. 2020; 10(4): 324-329. doi:10.5455/njppp.2020.10.11365201921122019 Web Style Mallya NV, Palakal S, G D. Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?. https://www.njppp.com/?mno=73780 [Access: March 15, 2024]. doi:10.5455/njppp.2020.10.11365201921122019 AMA (American Medical Association) Style Mallya NV, Palakal S, G D. Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?. Natl J Physiol Pharm Pharmacol. 2020; 10(4): 324-329. doi:10.5455/njppp.2020.10.11365201921122019 Vancouver/ICMJE Style Mallya NV, Palakal S, G D. Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?. Natl J Physiol Pharm Pharmacol. (2020), [cited March 15, 2024]; 10(4): 324-329. doi:10.5455/njppp.2020.10.11365201921122019 Harvard Style Mallya, N. V., Palakal, . S. & G, . D. (2020) Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?. Natl J Physiol Pharm Pharmacol, 10 (4), 324-329. doi:10.5455/njppp.2020.10.11365201921122019 Turabian Style Mallya, Nalini Vivek, Sreedhar Palakal, and Dayananda G. 2020. Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?. National Journal of Physiology, Pharmacy and Pharmacology, 10 (4), 324-329. doi:10.5455/njppp.2020.10.11365201921122019 Chicago Style Mallya, Nalini Vivek, Sreedhar Palakal, and Dayananda G. "Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 324-329. doi:10.5455/njppp.2020.10.11365201921122019 MLA (The Modern Language Association) Style Mallya, Nalini Vivek, Sreedhar Palakal, and Dayananda G. "Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?." National Journal of Physiology, Pharmacy and Pharmacology 10.4 (2020), 324-329. Print. doi:10.5455/njppp.2020.10.11365201921122019 APA (American Psychological Association) Style Mallya, N. V., Palakal, . S. & G, . D. (2020) Could neutrophil-lymphocyte ratio be an adjuvant marker for cognitive impairment in patients with Type 2 diabetes mellitus?. National Journal of Physiology, Pharmacy and Pharmacology, 10 (4), 324-329. doi:10.5455/njppp.2020.10.11365201921122019 |